Idaho Bill Rejecting FDA Restrictions on Terminal Patients Passes House 66-1
BOISE, Idaho (Feb. 29, 2016) – An Idaho bill that would set the foundation nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients passed the House by an overwhelming margin today. The House of Delegates Health and Welfare Committee introduced House Bill 481 (H481)…